United States · Research startup

Ossium Health

Ossium Health is a bioengineering and therapeutics company based in San Francisco, California, founded in 2016.

Funding reportedLast round: Series C

ResearchSan Francisco, United States

About Ossium Health

Ossium Health is a bioengineering and therapeutics company based in San Francisco, California, founded in 2016.

The company has created the world’s first deceased donor bone marrow bank, which provides on-demand stem cell therapies for patients with life-threatening blood cancers, immune diseases, organ transplant rejection, and musculoskeletal defects. Ossium Health's mission is to enhance human health, vitality, and longevity through innovative bioengineering solutions. The company offers a range of stem cell-based therapies and orthopedic products. Their therapies include hematopoietic progenitor cells for blood cancer treatment, mesenchymal stem cell therapy for tissue healing, and viable bone matrix allografts for bone repair. Ossium Health serves various customer segments, including patients, healthcare providers, research institutions, and government agencies, and has established partnerships to support national emergency preparedness. With significant funding and a strong market position, Ossium Health is advancing the field of stem cell therapy.

What company datasets say Ossium Health raised

Funding, as reported

Reported in all$129Min dollars
Rounds6
Last roundSeries C
Last round size$52M
Last round dateJul 2023
Investors listed15
SEC Form D$10M sold, 1 filing, last May 2018

Founders and team

From Ossium Health's own website and the SEC filings it signed: 2 founders, 50 on the team.

Kevin CaldwellCEO, Co-Founder & PresidentNamed on its 2018 Form D
Erik WoodsChief Science Officer, Co-Founder, EVP, CLIA Laboratory DirectorNamed on its 2018 Form D
  • Sagar MunjalChief Medical Officer, Senior Vice President
  • Brian JohnstoneVice President, Research
  • Chip Walker-WilsonGeneral Counsel & Senior Vice President
  • Ed JunVice President, Finance
  • Hans NowakSenior Vice President, Manufacturing Operations
  • Jay GardnerVice President, People & Talent
  • Kathleen VasilopulosVice President, Donor Operations
  • Andrew BruhnExecutive Assistant to the Chief Science Officer
  • Dawson RayChief of Staff
  • Jessica BridghamExecutive Assistant to the Chief Science Officer
  • Susannah CantrellChief Commercial Officer
  • Alex WilliamsClinical Trial Manager
  • Alyssa Ochoa-MenaLead Donation Compliance Specialist
  • Behdad PournaderDirector, Technology
  • Brennan BochenekManager, Revenue Operations & Customer/Patient Support
  • Brett BowersockQuality Control Associate I
  • Brianna LoweryCell Therapy Associate III, Clinical Production
  • Cody MartinezExecutive Assistant & Office Manager

And 32 more on the team.

On the board, as filediSebastian GiwaThomas CycyotaWilliam Trenchard

On 3 portfolio pages

Investors who name them

Each firm lists Ossium Health on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

The company, in detail

What they build

Known for

hspc cryopreservationdonor tissue recoveryhealth carebone marrow bankcell therapy supply chaincell therapy for hematologic malignanciescell cryopreservation protocolsstem cell transplantbiotechnology researchcell therapy manufacturing scalevacuum infiltrationdistributionmanufacturingcell engraftmentcell therapieshematologic diseases

Built with from their website

Google Tag ManagerWordPress.orgSalesforce CRM AnalyticsHREF LangAtlassianPWAGoogle CloudMicrosoft PowerPointGoogle WorkspaceCloudFlare

+8 more

GemViewport MetaSite KitElement UIHubspot.NETAll in One SEOGoogle Meet

Sector
Research
Industry code
NAICS 33911, 541714, 621511, SIC 2834
Region
California
Revenue
$17M a year, as listed
Full record
Every detail in the company directory

Research in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Ossium Health in front of investors. Or tell us what we have wrong.